Pfizer Inc. (PFE) Discusses New Phase IIb Data and Development Plans for Berobenatide GLP-1 Receptor Agonist in Obesity - Slideshow (NYSE:PFE) 2026-06-17

Stocks Seeking Alpha By Seeking Alpha 17 Jun 2026 19:43 1 min read

Pfizer Inc. (PFE) Discusses New Phase IIb Data and Development Plans for Berobenatide GLP-1 Receptor Agonist in Obesity - Slideshow (NYSE:PFE) 2026-06-17 Seeking Alpha

Read the full story on Seeking Alpha → Opens the original article on news.google.com

Summary aggregated from Seeking Alpha's public RSS feed. The full reporting belongs to Seeking Alpha — please read it on their site.